TY - JOUR
T1 - Prospective derivation of a living organoid biobank of colorectal cancer patients
AU - Van De Wetering, Marc
AU - Francies, Hayley E.
AU - Francis, Joshua M.
AU - Bounova, Gergana
AU - Iorio, Francesco
AU - Pronk, Apollo
AU - Van Houdt, Winan
AU - Van Gorp, Joost
AU - Taylor-Weiner, Amaro
AU - Kester, Lennart
AU - McLaren-Douglas, Anne
AU - Blokker, Joyce
AU - Jaksani, Sridevi
AU - Bartfeld, Sina
AU - Volckman, Richard
AU - Van Sluis, Peter
AU - Li, Vivian S.W.
AU - Seepo, Sara
AU - Sekhar Pedamallu, Chandra
AU - Cibulskis, Kristian
AU - Carter, Scott L.
AU - McKenna, Aaron
AU - Lawrence, Michael S.
AU - Lichtenstein, Lee
AU - Stewart, Chip
AU - Koster, Jan
AU - Versteeg, Rogier
AU - Van Oudenaarden, Alexander
AU - Saez-Rodriguez, Julio
AU - Vries, Robert G.J.
AU - Getz, Gad
AU - Wessels, Lodewyk
AU - Stratton, Michael R.
AU - McDermott, Ultan
AU - Meyerson, Matthew
AU - Garnett, Mathew J.
AU - Clevers, Hans
N1 - Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/5/7
Y1 - 2015/5/7
N2 - In Rspondin-based 3D cultures, Lgr5 stem cells from multiple organs form ever-expanding epithelial organoids that retain their tissue identity. We report the establishment of tumor organoid cultures from 20 consecutive colorectal carcinoma (CRC) patients. For most, organoids were also generated from adjacent normal tissue. Organoids closely recapitulate several properties of the original tumor. The spectrum of genetic changes within the "living biobank" agrees well with previous large-scale mutational analyses of CRC. Gene expression analysis indicates that the major CRC molecular subtypes are represented. Tumor organoids are amenable to high-throughput drug screens allowing detection of gene-drug associations. As an example, a single organoid culture was exquisitely sensitive to Wnt secretion (porcupine) inhibitors and carried a mutation in the negative Wnt feedback regulator RNF43, rather than in APC. Organoid technology may fill the gap between cancer genetics and patient trials, complement cell-line- and xenograft-based drug studies, and allow personalized therapy design.
AB - In Rspondin-based 3D cultures, Lgr5 stem cells from multiple organs form ever-expanding epithelial organoids that retain their tissue identity. We report the establishment of tumor organoid cultures from 20 consecutive colorectal carcinoma (CRC) patients. For most, organoids were also generated from adjacent normal tissue. Organoids closely recapitulate several properties of the original tumor. The spectrum of genetic changes within the "living biobank" agrees well with previous large-scale mutational analyses of CRC. Gene expression analysis indicates that the major CRC molecular subtypes are represented. Tumor organoids are amenable to high-throughput drug screens allowing detection of gene-drug associations. As an example, a single organoid culture was exquisitely sensitive to Wnt secretion (porcupine) inhibitors and carried a mutation in the negative Wnt feedback regulator RNF43, rather than in APC. Organoid technology may fill the gap between cancer genetics and patient trials, complement cell-line- and xenograft-based drug studies, and allow personalized therapy design.
UR - http://www.scopus.com/inward/record.url?scp=84928974420&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2015.03.053
DO - 10.1016/j.cell.2015.03.053
M3 - Article
C2 - 25957691
AN - SCOPUS:84928974420
SN - 0092-8674
VL - 161
SP - 933
EP - 945
JO - Cell
JF - Cell
IS - 4
ER -